Common-Size Income Statement
Paying user area
Try for free
Elevance Health Inc. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Analysis of Reportable Segments
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Current Ratio since 2005
- Debt to Equity since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Elevance Health Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Elevance Health Inc., common-size consolidated income statement
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Income statement item | Description | The company |
|---|---|---|
| Operating income | The net result for the period of deducting operating expenses from operating revenues. | Elevance Health Inc. operating income as a percentage of operating revenue decreased from 2021 to 2022 and from 2022 to 2023. |
| Income before income tax expense | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Elevance Health Inc. income before income tax expense as a percentage of operating revenue decreased from 2021 to 2022 and from 2022 to 2023. |
| Shareholders’ net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Elevance Health Inc. shareholders’ net income as a percentage of operating revenue decreased from 2021 to 2022 and from 2022 to 2023. |